Bank of New York Mellon’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Buy |
+134,287
| New | +$199K | ﹤0.01% | 3969 |
|
|
2024
Q2 | – | Sell |
-173,206
| Closed | -$218K | – | 4220 |
|
|
2024
Q1 | $218K | Sell |
173,206
-5,289
| -3% | -$6.66K | ﹤0.01% | 3897 |
|
|
2023
Q4 | $318K | Buy |
178,495
+12,815
| +8% | +$22.8K | ﹤0.01% | 3768 |
|
|
2023
Q3 | $275K | Buy |
165,680
+18,760
| +13% | +$31.1K | ﹤0.01% | 3837 |
|
|
2023
Q2 | $294K | Buy |
+146,920
| New | +$294K | ﹤0.01% | 3830 |
|
|
2018
Q1 | – | Sell |
-1,162
| Closed | -$8K | – | 4372 |
|
|
2017
Q4 | $8K | Buy |
+1,162
| New | +$8K | ﹤0.01% | 4322 |
|
|
2015
Q1 | – | Sell |
-1,986
| Closed | -$36K | – | 4236 |
|
|
2014
Q4 | $36K | Buy |
+1,986
| New | +$36K | ﹤0.01% | 4149 |
|